CytomX Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on CytomX Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date CytomX Therapeutics Inc Strategy Report
- Understand CytomX Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
CytomX Therapeutics Inc (CytomX) is a clinical-stage biopharmaceutical company. it develops novel therapeutic antibodies and Probody therapeutics for the treatment of cancer. The company product pipeline include CX-2029, CX-904 and BMS-986288. Its pipeline carries out SqNSCLC, esophageal/GEJ and solid tumors. CytomX also provides probody therapeutics for the treatment of cancer. It has collaborated with Abbvie, Amgen, Astellas, Regeneron and Moderna among others. The company also carries out various phases of clinical trails. CytomX is headquartered in South San Francisco, California, the US.
Headquarters
United States of America
Address
151 Oyster Point Blvd., Suite 400, South San Francisco, California, 94080
Website
cytomx.com
Telephone
1 650 5153185
No of Employees
120
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
CTMX (NASD)
Revenue (2022)
$101.2M
90.4%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
99.4%
(2022 vs 2021)
Market Cap*
$108.4M
Net Profit Margin (2022)
XYZ
99.7%
(2022 vs 2021)
* As of and is in US$
CytomX Therapeutics Inc premium industry data and analytics
Products and Services
| Products |
|---|
| CX-2029 - SqNSCLC, Esophageal/GEJ |
| CX-904 - Solid Tumors |
| BMS-986288 - Solid tumors |
Competitor Comparison
| Key Parameters | CytomX Therapeutics Inc | AbbVie Inc | Amgen Inc | Halozyme Therapeutics Inc | Harpoon Therapeutics Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | South San Francisco | North Chicago | Thousand Oaks | San Diego | South San Francisco |
| State/Province | California | Illinois | California | California | California |
| No. of Employees | 120 | 50,000 | 26,700 | 373 | 53 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Sean A. McCarthy | Chairman; Chief Executive Officer | Executive Board | 2018 | 56 |
| Lloyd A. Rowland | Senior Vice President; Chief Compliance Officer; General Counsel; Secretary | Senior Management | 2018 | 66 |
| Wayne Chu | Chief Medical Officer | Senior Management | - | - |
| Marcia P. Belvin Ph.D. | Senior Vice President; Chief Scientific Officer | Senior Management | 2020 | - |
| Leslie Robbins | Senior Vice President - Intellectual Property | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer